Establishing the platform for clinical gene therapy of p47phox chronic granulomatous disease (CGD)

被引:0
|
作者
Schejtman, A. [1 ]
Cutrim Arago Filho, W. [2 ]
Zinicola, M. [1 ]
Siler, U. [3 ]
Reichenbach, J. [3 ]
Gaspar, H. B. [1 ]
Condino-Neto, A. [2 ]
Thrasher, A. J. [1 ]
Santilli, G. [1 ]
机构
[1] UCL, Inst Child Hlth, London, England
[2] Univ Sao Paulo, Sao Paulo, Brazil
[3] Univ Childrens Hosp Zurich, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P227
引用
收藏
页码:A114 / A115
页数:2
相关论文
共 50 条
  • [31] NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis
    Kuhns, Douglas B.
    Hsu, Amy P.
    Sun, David
    Lau, Karen
    Fink, Danielle
    Griffith, Paul
    Huang, Wei
    Priel, Debra A. Long
    Mendez, Laura
    Kreuzburg, Samantha
    Zerbe, Christa S.
    De Ravin, Suk See
    Malech, Harry L.
    Holland, Steven M.
    Wu, Xiaolin
    Gallin, John, I
    BLOOD ADVANCES, 2019, 3 (02) : 136 - 147
  • [32] Prophylactic interferon-gamma is effective in the P47(PHOX) deficient mouse model of chronic granulomatous disease (CGD).
    Jackson, SH
    Gallin, JI
    Miller, GF
    Holland, SM
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A320 - A320
  • [33] Diabetes and Cardiovascular Disease in p47phox-/- Chronic Granulomatous Disease
    Leiding, Jennifer W.
    Marciano, Beatriz E.
    DeRavin, Suk See
    Malech, Harry L.
    Holland, Steven M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 389 - 389
  • [34] Development of a Prime Edited CD34+Cell Drug Product for the Treatment of P47phox Chronic Granulomatous Disease
    Heath, Jack M.
    Stewart-Ornstein, Jacob
    Osuna, Christa E.
    Arabiyat, Ahmad S.
    Tedeschi, Justin G.
    Collier, Maria
    Kushakji, Julia
    Ng, Allen C.
    Lilieholm, Marina
    Wilhelm, Alan
    Green, Katie
    Subramanian, Hari Prasanna
    Trusiak, Sarah
    Kosheleva, Katya
    Irby, Matthew J.
    Alam, Rowshon
    Elich, Joseph
    Ta, Terence
    De Ravin, Suk See
    Malech, Harry L.
    Nehilla, Barrett J.
    Patel, Hetal K.
    Beard, Brian C.
    Duffield, Jeremy S.
    Gori, Jennifer L.
    MOLECULAR THERAPY, 2024, 32 (04) : 55 - 55
  • [35] Lentiviral gene therapy for p22phox deficient chronic granulomatous disease
    Cozmescu, Claudiu A.
    Schejtman, Andrea
    Zinicola, Marta
    Thrasher, Adrian J.
    Santilli, Giorgia
    HUMAN GENE THERAPY, 2018, 29 (07) : A8 - A8
  • [36] p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease
    Gouri P. Hule
    Purva R. Kanvinde
    Manasi A. Kulkarni
    Karin van Leeuwen
    Martin de Boer
    Umair Ahmed Bargir
    Prasad D. Taur
    Mukesh M. Desai
    Manisha R. Madkaikar
    Journal of Clinical Immunology, 2018, 38 : 638 - 641
  • [37] p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease
    Hule, Gouri P.
    Kanvinde, Purva R.
    Kulkarni, Manasi A.
    van Leeuwen, Karin
    de Boer, Martin
    Bargir, Umair Ahmed
    Taur, Prasad D.
    Desai, Mukesh M.
    Madkaikar, Manisha R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (06) : 638 - 641
  • [38] The p47-phox gene has a pseudogene carrying the most common mutation for p47-phox deficient chronic granulomatous disease.
    Gorlach, A
    Roesler, J
    Hopkins, PJ
    Christensen, BL
    Lee, P
    Green, ED
    Chanock, SJ
    Curnutte, JT
    BLOOD, 1995, 86 (10) : 1027 - 1027
  • [39] Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous Disease
    Schejtman, Andrea
    Vetharoy, Winston
    Choi, Uimook
    Rivat, Christine
    Theobald, Narda
    Piras, Giuseppa
    Leon-Rico, Diego
    Buckland, Karen
    Armenteros-Monterroso, Elena
    Benedetti, Sara
    Ashworth, Michael T.
    Rothe, Michael
    Schambach, Axel
    Gaspar, Hubert Bobby
    Kang, Elizabeth M.
    Malech, Harry L.
    Thrasher, Adrian J.
    Santilli, Giorgia
    HUMAN GENE THERAPY, 2021, 32 (17-18) : 949 - 958
  • [40] Clinical presentation, diagnosis and therapy of granulomatous inflammations in patients with chronic granulomatous disease (CGD)
    von Bernuth, H
    Knöchel, B
    Wendisch, J
    Bergert, R
    Winkler, U
    Hahn, G
    Rupprecht, E
    Roesler, J
    Gahr, M
    MONATSSCHRIFT KINDERHEILKUNDE, 2003, 151 (01) : 49 - 56